Literature DB >> 24108555

Spectrum of pulmonary neuroendocrine proliferations and neoplasms.

Ryo E C Benson1, Melissa L Rosado-de-Christenson, Santiago Martínez-Jiménez, Jeffrey R Kunin, Paul P Pettavel.   

Abstract

Neuroendocrine neoplasms are ubiquitous tumors found throughout the body, most commonly in the gastrointestinal tract followed by the thorax. Neuroendocrine cells occur normally in the bronchial and bronchiolar epithelium and may be solitary or may occur in clusters. Although neuroendocrine cell proliferations may be found in association with chronic lung disease, a broad range of neuroendocrine proliferations and neoplasms may occur and exhibit variable biologic behavior. Diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) is a diffuse idiopathic form of neuroendocrine cell hyperplasia and is considered a preinvasive lesion that may give rise to carcinoid tumors. Patients with DIPNECH are typically older women who may be asymptomatic or may present with chronic respiratory symptoms. DIPNECH manifests as multifocal bilateral pulmonary micronodules on expiratory high-resolution computed tomographic (CT) images; the air trapping is secondary to constrictive bronchiolitis. Carcinoid tumors are low-grade malignant neoplasms that typically affect symptomatic children and young adults. Carcinoids manifest as well-defined pulmonary nodules or masses that are often closely related to central bronchi. They may exhibit intrinsic calcification and contrast material enhancement at CT, and patients with carcinoids may have postobstructive atelectasis and pneumonia. Although typical carcinoids are indolent neoplasms and patients have a good prognosis, atypical carcinoids are aggressive malignancies with a propensity for metastasis. Both are optimally treated with complete surgical excision. Large cell neuroendocrine carcinoma and small cell lung cancer are highly aggressive neuroendocrine malignancies that usually affect elderly smokers. These tumors manifest with large peripheral or central pulmonary masses. Local invasion, intrathoracic lymphadenopathy, and distant metastases are frequent at presentation. As a result, affected patients may not be candidates for surgical resection, are often treated with chemotherapy with or without radiation, and have a poor prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 24108555     DOI: 10.1148/rg.336135506

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  15 in total

Review 1.  PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.

Authors:  Filippo Lococo; Alfredo Cesario; Massimiliano Paci; Angelina Filice; Annibale Versari; Cristian Rapicetta; Tommaso Ricchetti; Giorgio Sgarbi; Marco Alifano; Alberto Cavazza; Giorgio Treglia
Journal:  Tumour Biol       Date:  2014-05-22

2.  Evolving role of PET/CT with different tracers in the evaluation of pulmonary neuroendocrine tumours.

Authors:  Giorgio Treglia; Luca Giovanella; Filippo Lococo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-21       Impact factor: 9.236

Review 3.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

4.  A case of multiple lung carcinoid tumors localized in the right lower lobe.

Authors:  Yuho Maki; Kazuhiro Okada; Ryuji Nakamura; Yutaka Hirano; Toshiya Fujiwara; Rie Yamasaki; Kouichi Ichimura; Motoki Matsuura
Journal:  Respir Med Case Rep       Date:  2022-05-27

Review 5.  Management of pulmonary neuroendocrine tumors.

Authors:  Robert A Ramirez; Aman Chauhan; Juan Gimenez; Katharine E H Thomas; Ioni Kokodis; Brianne A Voros
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

6.  Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments.

Authors:  Dylan L Schaff; Shambhavi Singh; Kee-Beom Kim; Matthew D Sutcliffe; Kwon-Sik Park; Kevin A Janes
Journal:  Cancer Res       Date:  2021-02-02       Impact factor: 13.312

7.  Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature.

Authors:  Anne-Leen Deleu; Annouschka Laenen; Herbert Decaluwé; Birgit Weynand; Christophe Dooms; Walter De Wever; Sander Jentjens; Karolien Goffin; Johan Vansteenkiste; Koen Van Laere; Paul De Leyn; Kristiaan Nackaerts; Christophe M Deroose
Journal:  EJNMMI Res       Date:  2022-05-07       Impact factor: 3.434

8.  Hyperplasia and hypertrophy of pulmonary neuroepithelial bodies, presumed airway hypoxia sensors, in hypoxia-inducible factor prolyl hydroxylase-deficient mice.

Authors:  Jie Pan; Tammie Bishop; Peter J Ratcliffe; Herman Yeger; Ernest Cutz
Journal:  Hypoxia (Auckl)       Date:  2016-04-12

9.  CT findings of small cell lung carcinoma: Can recognizable features be found?

Authors:  Dongjun Lee; Ji Young Rho; Seunghun Kang; Koun Joy Yoo; Hye Jeong Choi
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 10.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Case Report and Review of the Literature.

Authors:  Evangelos Koliakos; Theodoros Thomopoulos; Ziad Abbassi; Christophe Duc; Michel Christodoulou
Journal:  Am J Case Rep       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.